Home2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Previous close
$13.98
Day range
$13.44 - $13.98
Year range
$11.52 - $19.50
Market cap
59.53B HKD
Avg Volume
5.38M
P/E ratio
18.73
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 9.42B | -7.26% |
Operating expense | 3.85B | -6.02% |
Net income | 764.76M | 25.42% |
Net profit margin | 8.12 | 35.33% |
Earnings per share | — | — |
EBITDA | 1.28B | -22.50% |
Effective tax rate | 30.13% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.07B | 6.98% |
Total assets | 117.99B | 3.73% |
Total liabilities | 57.14B | 1.66% |
Total equity | 60.85B | — |
Shares outstanding | 2.64B | — |
Price to book | 0.77 | — |
Return on assets | 1.37% | — |
Return on capital | 1.68% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 764.76M | 25.42% |
Cash from operations | 1.06B | 15.08% |
Cash from investing | -185.09M | 84.46% |
Cash from financing | -633.63M | -742.38% |
Net change in cash | 245.87M | 262.03% |
Free cash flow | -1.89B | -2.13% |
About
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Founded
1994
Website
Employees
40,557
